Overview of: Medicines and Healthcare products Regulatory Agency. Ingenol mebutate gel (Picato▼): suspension of the licence due to risk of skin malignancy. Drug Safety Update 2020;13(7):1.
Keywords: adherence; adverse effects.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.